Patent · US Active

6-substituted quinazolinone inhibitors

US10532999B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignees

University of Kansas · US
University of Louisville Research Foundation, Inc. · US
Southern Research Institute · US

Inventors

Jennifer E. Golden · Olathe, US
Jeffrey Aube · Lawrence, US
Donghoon Chung · Louisville, US
Chad E. Schroeder · Lawrence, US
Tuanli Yao · Lawrence, US
E. Lucile White · Birmingham, US
Nichole A. Tower · Birmingham, US

Key dates

Filing date	Oct 1, 2018
Grant date	Jan 14, 2020
Priority date	—
Expiry date	Oct 1, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.